Biblio
Export 222 results:
[ Author
Filters: First Letter Of Last Name is B [Clear All Filters]
“Low Arousal Positive Emotional Stimuli Attenuate Aberrant Working Memory Processing in Persons with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1333-1349, 2017.
, “A High-Cholesterol Diet Increases 27-Hydroxycholesterol and Modifies Estrogen Receptor Expression and Neurodegeneration in Rabbit Hippocampus.”, J Alzheimers Dis, vol. 56, no. 1, pp. 185-196, 2017.
, “Genotyping of the Alzheimer's Disease Genome-Wide Association Study Index Single Nucleotide Polymorphisms in the Brains for Dementia Research Cohort.”, J Alzheimers Dis, vol. 64, no. 2, pp. 355-362, 2018.
, “A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1509-1519, 2016.
, “Diagnostic Distortions: A Case Report of Progressive Apraxia of Speech.”, J Alzheimers Dis, vol. 53, no. 1, pp. 79-83, 2016.
, “A Novel Antibody Targeting Tau Phosphorylated at Serine 235 Detects Neurofibrillary Tangles.”, J Alzheimers Dis, vol. 61, no. 3, pp. 899-905, 2018.
, “Age-Related Intraneuronal Aggregation of Amyloid-β in Endosomes, Mitochondria, Autophagosomes, and Lysosomes.”, J Alzheimers Dis, vol. 73, no. 1, pp. 229-246, 2020.
, “Divalent Copper as a Major Triggering Agent in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
, “Depressive Symptoms Imputed Across the Life Course Are Associated with Cognitive Impairment and Cognitive Decline.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1379-1389, 2021.
, “Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms.”, J Alzheimers Dis, vol. 65, no. 3, pp. 793-806, 2018.
, “Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III Studies.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1409-1424, 2018.
, “Preliminary Report on the Feasibility and Efficacy of the Modified Atkins Diet for Treatment of Mild Cognitive Impairment and Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 68, no. 3, pp. 969-981, 2019.
, “Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer's Mouse Model.”, J Alzheimers Dis, vol. 56, no. 2, pp. 775-788, 2017.
, “A Novel Plasma Based Biomarker of Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 3, pp. 761-71, 2015.
, “Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.”, J Neuropathol Exp Neurol, vol. 70, no. 11, pp. 960-9, 2011.
, “Abnormalities of Cerebral Deep Medullary Veins on 7 Tesla MRI in Amnestic Mild Cognitive Impairment and Early Alzheimer's Disease: A Pilot Study.”, J Alzheimers Dis, vol. 57, no. 3, pp. 705-710, 2017.
, “Single Subject Classification of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Anatomical, Diffusion Tensor, and Resting-State Functional Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1827-1839, 2018.
, “The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer's Disease During the COVID-19 Crisis.”, J Alzheimers Dis, vol. 76, no. 1, pp. 41-47, 2020.
, “Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1069-83, 2016.
, “Early Emotional Attention is Impacted in Alzheimer's Disease: An Eye-Tracking Study.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1445-1458, 2018.
, “Anti-Viral Properties of Amyloid-β Peptides.”, J Alzheimers Dis, vol. 54, no. 3, pp. 859-878, 2016.
, “Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1227-41, 2016.
, “Effect of Metabolic Syndrome Risk Factors on Processing Speed and Executive Function in Three Racialized Groups.”, J Alzheimers Dis, vol. 92, no. 1, pp. 285-294, 2023.
, “Brain Volume Predicts Behavioral and Psychological Symptoms in Alzheimer's Disease.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1343-1353, 2020.
, “Neuropsychiatric Symptoms in Patients with Neurocognitive Disorder and Their Performance Between Mild and Major Stages.”, J Alzheimers Dis, vol. 85, no. 4, pp. 1735-1744, 2021.
,